Simrat Randhawa
2023
In 2023, Simrat Randhawa earned a total compensation of $338.2K as Chief Medical Officer at Dianthus Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $198,663 |
---|---|
Salary | $139,495 |
Total | $338,158 |
Randhawa received $198.7K in non-equity incentive plan, accounting for 59% of the total pay in 2023.
Randhawa also received $139.5K in salary.
Rankings
In 2023, Simrat Randhawa's compensation ranked 2,429th out of 3,006 executives tracked by ExecPay. In other words, Randhawa earned more than 19.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,429 out of 3,006 | 19th |
Division Manufacturing | 1,361 out of 1,650 | 18th |
Major group Chemicals And Allied Products | 797 out of 918 | 13th |
Industry group Drugs | 778 out of 881 | 12th |
Industry Pharmaceutical Preparations | 559 out of 637 | 12th |
Source: SEC filing on April 11, 2024.
Randhawa's colleagues
We found six more compensation records of executives who worked with Simrat Randhawa at Dianthus Therapeutics in 2023.
2023
Stephen Mahoney
Dianthus Therapeutics
Former President, Chief Financial and Operating Officer
2023
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
2023
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
2023
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
2023
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
2023
Ryan Savitz
Dianthus Therapeutics